Mucormycosis.
Czech MM, Cuellar-Rodriguez J.
Infect Dis Clin North Am. 2025 Mar;39(1):121-144. doi: 10.1016/j.idc.2024.11.008. Epub 2024 Dec 4.
Epidemiology, pathogenesis, clinical characteristics, and treatment of mucormycosis: a review.
Liang M, Xu J, Luo Y, Qu J.
Ann Med. 2024 Dec;56(1):2396570. doi: 10.1080/07853890.2024.2396570. Epub 2024 Sep 2.
Mucormycosis.
Kontoyiannis DP, Walsh TJ.
N Engl J Med. 2026 Feb 12;394(7):684-698. doi: 10.1056/NEJMra2412565.
Mucormycosis in COVID-19 patients.
Sundaram N, Bhende T, Yashwant R, Jadhav S, Jain A.
Indian J Ophthalmol. 2021 Dec;69(12):3728-3733. doi: 10.4103/ijo.IJO_1316_21.
Mucormycosis threats: A systemic review.
Prakash S, Kumar A.
J Basic Microbiol. 2023 Feb;63(2):119-127. doi: 10.1002/jobm.202200334. Epub 2022 Nov 4.
Mucormycosis medications: a patent review.
Imran M, A S A, Tauseef M, Khan SA, Hudu SA, Abida.
Expert Opin Ther Pat. 2021 Nov;31(11):1059-1074. doi: 10.1080/13543776.2021.1939308. Epub 2021 Jun 18.
Mucormycosis: A Rare disease to Notifiable Disease.
Panda S, Sahu MC, Turuk J, Pati S.
Braz J Microbiol. 2024 Jun;55(2):1065-1081. doi: 10.1007/s42770-024-01315-z. Epub 2024 Apr 1.
Mucormycosis.
Sugar AM.
Clin Infect Dis. 1992 Mar;14 Suppl 1:S126-9. doi: 10.1093/clinids/14.supplement_1.s126.
Mucormycosis of the Mandible and Tongue: A Systematic Scoping Review.
Fakhruddin KS, Matsubara VH, Warnakulasuriya S, Tilakaratne WM, Ngo HC, Samaranayake LP.
Int Dent J. 2024 Jun;74(3):454-472. doi: 10.1016/j.identj.2023.11.011. Epub 2023 Dec 23.
[Mucormycosis in the time of COVID-19: risks and challenges].
Seidel D, Sal E, Nacov JA, Cornely OA, Kurzai O.
Dtsch Med Wochenschr. 2024 May;149(10):569-578. doi: 10.1055/a-2139-3902. Epub 2024 Apr 24.
